Latest news
New research suggests that fetal hemostasis is distinct and that impairment of angiogenesis rather than thrombocytopenia likely causes FNAIT-associated ICH. Additionally, our results indicate that maternal IVIG therapy can effectively prevent this devastating disorder.
New research suggests that fetal hemostasis is distinct and that impairment of angiogenesis rather than thrombocytopenia likely causes FNAIT-associated ICH. Additionally, results indicate that maternal IVIG […]Natural Killer Cells Contribute to Pathophysiology of Placenta Leading to Miscarriage in Fetal and Neonatal Alloimmune Thrombocytopenia
Many women diagnosed with NAIT suffer multiple miscarriage. This is the first study to investigate the pathophysiology between miscarriage and NAIT. From researchers in Toronto, Canada. […]PROFNAIT an important initiative at the forefront of research into FNAIT/NAIT
Hope for rare disease blood carriers PROFNAIT and how this project could save babies lives……. by Professor Jens KJeldsen-Kragh NAIT occurs when the platelet type […]
See Naitbabies news in today’s national newspaper The Independent-Genetics Disorder Campaign 2015
Read how Andrea Palmer and her daughter Senen age 7 have been affected by NAIT in the ‘Genetic disorders Campaign 2015’ featured in The Independent newspaper […]
Poster showing Initial data from the Australian NAIT Registry
Initial summary of data from the Australian NAIT Registry Prepared by Ri Scarborough, Project Officer.
Prophylix Pharma AS (PROFNAIT Project) will take NAITgam into Phase I/II trials in Q3 2015.
TROMSØ, Norway, Oct 02, 2014 (BUSINESS WIRE) — Prophylix Pharma today announced that it will take its novel prophylactic NAITgam into Phase I/II trials in Q3 […]
EXCITING INVITATION!!!!!
We are delighted that all families from our organization have been invited by Dr. James Bussel to attend this amazing event being held on 22nd March […]
Neonatal Alloimmune Thrombocytopenia – NAIT Survey Study request.
NAIT mothers from any country who have had a treated pregnancy are requested to take part in in this study. Please read the flyer for […]
Breaking News!
Tromplate® the medicine being developed by the PROFNAIT Project, which has already been granted Orphan Drug Status in the EU has just been granted Orphan Drug […]
